WHO在2021年7月发布了最新版本的《关于HIV预防,检测,治疗,服务提供和监测的综合指南:公共卫生方法的建议》,该指南在WHO 2016年《关于使用抗反转录病毒药物治疗和预防HIV感染的综合指南:公共卫生方法的建议》的基础之上进行了最新证据的更新,从HIV预防与治疗以外的多个视角给出了最新的推荐意见.本文主要从2021年新版...
Women living with HIV have a 6-fold increased risk of developing cervical cancer compared to women without HIV. In 2021 WHO published the second edition of guidelines for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, including 16 new 载入中...手动刷新 ...
但是目前没有现成可用的检测方法(包括NAT检测方法)可以在HIV感染的早期检测到HIV感染。 (译注:2021年版《中国艾滋病诊疗指南》介绍核酸检测的临床意义:可作为HIV感染诊断的补充试验,用于急性期/窗口期以及晚期患者的诊断、HIV感染者的诊断...
2022+WHO指南:长效注射型卡博特韦用于HIV的预防.pdf,GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION GUIDELINES ON LONG-ACTING INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION Guidelines on long-acting injectable cabotegravir for HIV preventi
WHO2024烟草和艾滋病毒报告.pdf,July 2024 Tobacco and HIV ▪ Prevalence of tobacco use among people living with HIV is more than double that of the general population. s ▪ Access to antiretroviral therapy has contributed to increase in life expectancy
Although people who inject drugs (PWID) are at high risk of acquiring HIV, knowledge and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among
Guan WM, Pan W, Yu W, Cao W, Lin Q, Zhang ZZ, Song XJ, Li YL, Tian JP, Xu Y, Li TS (2021) Changes in trabecular bone score and bone mineral density in Chinese HIV-Infected individuals after one year of antiretroviral therapy. Journal of Orthopaedic Translation 29:72–77 Article ...
2. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024. Licence: CC BYNC-SA 3.0 IGO. 3. Easterbrook P, Sands A, Harmanci H. Challenges and priorities in the management of HIV/HBV and HIV/HCV ...
2. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024. Licence: CC BYNC-SA 3.0 IGO. 3. Easterbrook P, Sands A, Harmanci H. Challenges and priorities in the management of HIV/HBV and HIV/HCV ...
Published Online:January 27, 2021. doi:10.1001/jama.2021.0258 Conflict of Interest Disclosures:Dr van der Graaf reported she is a member of the independent Bioethics Advisory Committee to Sanofi. This committee does not advise on the ethics of HIV prevention trials. Dr Godfrey-Faussett reported gr...